ArticleInternational ophthalmology2024
Evaluation of optical coherence tomography and optical coherence tomography angiography findings of fibromyalgia.
Article in International ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo execute comprehensive study about optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) findings in fibromyalgia (FM) to elaborate macula, optic disk changes.
methodsA total of 84 participants comprising 44 FM patients and 40 healthy controls were included. Macular full thickness, retinal nerve fiber layer (RNFL), ganglion cell layer (GCL)+, GCL++, superficial vessel density (SVD), deep vessel density (DVD), foveal avascular zone (FAZ), circumpapillary vessel density (cpVD), RNFL measurements were evaluated using OCT/OCTA. Each FM patient completed Fibromyalgia Impact Questionnaire (FIQ), Short Form-36 (SF-36), Widespread Pain Index (WPI), Symptom Severity Scale (SSS). OCT/OCTA parameters were compared between controls and FM patients. Correlation between FIQ, SF-36, WPI, SSS and OCT/OCTA were evaluated. Logistic regression analysis were performed to analyze associated parameters.
resultsMacular full thickness parafoveal nasal, temporal, superior, inferior, perifoveal temporal, superior, GCL+ parafoveal nasal, temporal, superior, inferior, GCL+ perifoveal temporal, GCL++ parafoveal nasal, temporal, superior, inferior, GCL++ perifoveal nasal were lower in FM patients. Difference was not found in SVD, DVD or FAZ measurements. cpVD in nasal, superior, inferior were higher in FM patients. RNFL temporal was lower in FM patients. Weak correlations were observed between FIQ, SF-36, WPI, SSS scores and OCT/OCTA parameters. Superior cpVD was associated with FM due to logistic regression analysis.
conclusionsOCT/OCTA can provide objective supplementary measurements in the assessment of FM. Changes in measurements like RNFL, macula GCL, cpVD are important to evaluate the neuroretinal changes in FM.
Indexed as
Identifiers
39681820What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.